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INTRODUCTION
Pylephlebitis, defined as suppurative thrombosis of the
portal vein often associated with bacteremia, is a rare
and serious complication of intra-abdominal infections.
Prior to antibiotics, the mortality rate of this disease
approached 100%.1 The veins adjacent to the infection
are the first to be involved, with later spread to the portal
vein and possibly the mesenteric and splenic veins.2-3
Extension into the mesenteric veins can lead to bowel
necrosis and increased morbidity and mortality.2-4

CASE PRESENTATION
A 63-year old male with a history of hypertension
presented to the emergency department with one
week of progressively worsening malaise, chills,
severe fatigue, and right upper quadrant abdominal
pain. He was tachycardic with a heart rate of 120 and
hypotensive to 70/30 mm Hg. Exam revealed a mildly
distended abdomen with tenderness to palpation in
the right upper quadrant and right lower quadrant.
Laboratory studies were significant for a leukocytosis
with bandemia and an elevation of the total bilirubin
and alkaline phosphatase. Abdominal CT scan showed
mucosal thickening involving the rectosigmoid colon.
Nodular rounded lesions containing bubbles of air,
concerning for multiple abscesses, ran the length of the
recto-sigmoid colon and extended into the mesentery. A
thrombus was noted in the main portal vein and superior
mesenteric vein. There was heterogeneity in the left
hepatic lobe consistent with multiple hepatic abscesses.
Of note, the patient had a recent colonoscopy showing
multiple sigmoid diverticulae. He was started on broadspectrum antibiotics with vancomycin and piperacillintazobactam. He briefly required vasopressor support.
A heparin drip was also started to manage the portal
vein and superior mesenteric vein thrombosis. Blood
cultures eventually grew group C streptococcus, and
vancomycin was discontinued per the susceptibility
pattern. The patient was treated in the hospital for 14
days and was discharged on oral amoxicillin-clavulanic

acid for 14 additional days. During his stay, the patient
was bridged to warfarin with a goal INR of 2-3.

DIFFERENTIAL DIAGNOSIS
Upon presentation, the patient met severe sepsis
criteria and the focus was on resuscitation. The initial
radiology report was misinterpreted as concerning for
sigmoid cancer with hepatic metastasis, though the
portal vein thrombosis was correctly identified upon
re-examination with the staff radiologist.

OUTCOME AND FOLLOW-UP
Despite the initial delay in diagnosis, the patient was
still treated appropriately given his presentation. Surgery
was consulted; however, since there were multiple
small abscesses and no single large area to drain,
it was decided to repeat imaging after two weeks of
antibiotic treatment. On the repeat CT, the abscesses
had resolved, but the portal vein thrombosis persisted.
The patient showed great improvement over his
hospital course, and was doing well at his one month
follow-up with his primary care doctor. He was treated
with warfarin for a six month course.

DISCUSSION
The most common presentation of pylephlebitis is
fever and abdominal pain.4 Laboratory abnormalities
generally include leukocytosis with a left shift and
elevations in alkaline phosphatase 5,6 Our patient fit
these criteria.
Infections such as appendicitis and diverticulitis are the
most frequent predisposing conditions to pylephlebitis,
though other intra-abdominal infections have also been
implicated 1,7
Blood cultures are positive in 23-88% of patients. 1-4
When positive, organisms are usually bowel flora with
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Bacteroides fragilis and Escherichia coli being the most
common.2-4 This patient grew group C streptococcus,
which is somewhat less common, and his source was
diverticulitis. The diagnosis depends on identifying an
abdominal source of infection with an accompanying
portal vein thrombus 8-11 CT is most useful in both
respects.5,8,9 Much of the increase in incidence of this
disease can likely be attributed to the more prevalent
use of CT.8-12
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KEY POINTS
The mortality of pylephlebitis is estimated to be 11-32%.1,3,5
Prompt diagnosis and treatment are necessary for a
good outcome. This diagnosis should be considered
in all patients with abdominal pain and fever who are
found on CT to have an intra-abdominal infection with
a portal vein thrombus. Draw blood cultures and treat
with antibiotics for 4-6 weeks.9
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